Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 8
Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 9
Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 10
Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 11
Innovus Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 12
Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13
Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 17
Asset Purchase 17
Innovus Pharma Acquires Assets of Beyond Human for USD0.6 Million 17
Innovus Pharma Acquires Vesele from Trophikos 18
Innovus Pharma Amends Acquisition of Rights to Circumserum from Centric Research for up to USD7.5 Million 19
Innovus Pharma To Acquire Prescription Product Portfolio From Prospector Capital Partners II 20
Venture Financing 22
Innovus Pharma Raises US$0.33 Million In Venture Financing 22
Innovus Pharma To Raise US$1.1 Million In Venture Financing 23
Partnerships 24
Innovus Pharma Enters into Agreement with ACON Laboratories 24
Innovus Pharma Enters into Distribution Agreement with Laboratorios Q Pharma 25
Innovus Pharma Enters into Co-Marketing Agreement with DanaLife for Zestra 26
Innovus Pharma Enters Into Co-Promotion Agreement With Consortia Health For EjectDelay 27
Licensing Agreements 28
Innovus Pharma Plans to Enter into Licensing Agreement with University of Iowa Research Foundation 28
Luminarie Enters into Licensing Agreement with Innovus Pharma 29
Innovus Pharma Expands Licensing Agreement with Densmore for Zestra 30
Innovus Pharma Enters into Licensing Agreement with NTC 31
Innovus Pharma Enters into Licensing Agreement with J&H Co. for Zestra 32
Elis Pharma Enters into Licensing Agreement with Innovus Pharma for Zestra 33
Innovus Pharma Enters into Licensing Agreement with BroadMed for EjectDelay 34
Innovus Pharma Enters into Licensing Agreement with Seipel 35
Bio Task Enters into Licensing Agreement with Innovus Pharma 36
Khandelwal Labs Enters into Licensing Agreement with Innovus Pharma 37
Elis Pharma Enters into Licensing Agreement with Innovus Pharma 38
BroadMed Enters into Licensing Agreement with Innovus Pharma for Sensum+ 39
Innovus Pharma Entes into Licensing Agreement with Tabuk Pharma 40
Innovus Pharma Enters into Licensing Agreement with Sothema Labs 41
Orimed Pharma Expands Licensing Agreement with Innovus Pharma 42
Innovus Pharma Enters into Licensing Agreement with Tramorgan for Sensum+ 43
Innovus Pharma Enters Into Licensing Agreement With Ovation Pharma For EjectDelay 44
Innovus Pharma Enters Into License And Distribution Agreement With Ovation Pharma For Circumserum 45
Equity Offering 46
Innovus Pharma Raises Funds through Private Placement 46
Innovus Pharma Prices Public Offering of Shares for USD3.9 Million 47
Innovus Pharma Files Registration Statement for Public Offering of Shares and Warrants for up to USD5 Million 48
Innovus Pharma to Raise Funds in Public Offering of Shares 49
Innovus Pharma to Raise USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 50
Innovus Pharma Completes Private Placement Of Shares For US$0.13 Million 51
Innovus Pharma Completes Private Placement Of Shares For US$0.45 Million 52
Innovus Pharma Completes Private Placement Of Shares For US$4.5 Million 53
Debt Offering 54
Innovus Pharma Raises USD0.8 Million in Third and Final Tranche of Private Placement of 10% Notes Due 2017 54
Innovus Pharma Raises Additional USD0.75 Million in Private Placement of 10% Note Due 2017 55
Innovus Pharma Raises USD1.5 Million in Private Placement of 10% Note Due 2017 56
Innovus Pharma Raises USD0.5 Million in Private Placement of 5% Notes Due 2016 57
Innovus Pharma to Raise USD0.3 Million Private Placement of 5% Notes Due 2016 58
Innovus Pharma to Raise USD0.3 Million Private Placement of 5% Notes Due 2016 59
Innovus Pharma Raises USD0.1 Million in Private Placement of Notes 60
Innovus Pharma Raises USD0.1 Million in Private Placement of 8% Debentures 61
Innovus Pharma Amends Private Placement of 8% Debenture Due 2016 62
Innovus Pharma Raises USD0.3 Million in Private Placement of 10% Debentures due 2015 63
Innovus Pharma Raises USD0.4 Million in Private Placement of 8% Debentures due 2014 64
Innovus Pharma Raises USD0.1 Million in Private Pacement of Convertible Debt 65
Innovus Pharma Raises USD0.2 Million in Private Placement of 8% Debentures 66
Asset Transactions 67
Apricus Biosciences Acquires Remaining 50% Stake Of Rights To PrevOnco From Innovus Pharma 67
Acquisition 68
Innovus Pharma Acquires Novalere 68
Innovus Pharma Acquires Semprae Labs 69
Innovus Pharmaceuticals Inc – Key Competitors 70
Innovus Pharmaceuticals Inc – Key Employees 71
Innovus Pharmaceuticals Inc – Locations And Subsidiaries 72
Head Office 72
Other Locations & Subsidiaries 72
Recent Developments 73
Financial Announcements 73
Nov 14, 2017: Innovus Pharmaceuticals Reports Nine Month Net Revenue of $6.4 million and Net Loss Decrease of 51.6% Compared to the Same Period in 2016 73
Aug 14, 2017: Innovus Pharmaceuticals Reports a Quarterly Net Revenue Increase of 99.2% and Net Loss Decrease of 74.1% Compared to the Same Period in 2016 75
May 12, 2017: Innovus Pharmaceuticals Reports Quarterly Revenue for the First Quarter 2017 of $2.2 Million 76
Mar 06, 2017: Innovus Pharmaceuticals Reports Record Annual Revenues for the Full Year 2016 of $4.8 Million 77
Nov 10, 2016: Innovus Pharma Reports Record Quarterly Revenues for the Third Quarter of 2016, Increasing 947% to $1.9 Million, and Record Nine Months Ended September 2016 Revenues, Increasing 463% to $3.1 Million 78
Aug 11, 2016: Innovus Pharma (INNV) Quarterly Revenue Soars Past $1M on 446% Growth With Positive Cash Flow 79
Aug 09, 2016: Innovus Pharma Turns Cash Flow Positive With Over $1 Million in Revenues for the Second Quarter 2016 81
May 20, 2016: Innovus Pharma CEO Provides Shareholder Update and Conference Call 82
Corporate Communications 83
Aug 29, 2016: With Revenues Climbing, Innovus Pharma Adds Robert E. Hoffman as its Chief Financial Officer 83
Legal and Regulatory 84
Oct 18, 2017: Innovus Pharma Receives Approval from Health Canada for Vesele as a Natural Health Product 84
Jun 07, 2016: Innovus Pharma Announces the Filing of the Product Licenses for Zestra, Zestra Glide, EjectDelay and Sensum+ With the Indian FDA (Directorate General of Health Services) by Its Partner Khandelwal Laboratories 85
May 16, 2016: Upcoming PDUFA and ANDA Approval Dates Could Catalyze Innovus Pharma and Lipocine 86
Product News 87
Dec 01, 2016: Innovus Pharma Launches its Clinically Proven UriVarx Product for Bladder Health Through its Beyond Human Sales and Marketing Platform in the United States 87
Nov 14, 2017: Innovus Pharma Launches FlutiCare OTC Nasal Spray Allergy Relief in the U.S. 88
Oct 20, 2016: Innovus Pharmaceuticals Supplement Androferti Improves Male Fertility, says top medical expert 89
Oct 05, 2016: Innovus Pharma Initiates Pre-Clinical and Clinical Program Evaluating the Safety and Efficacy of Vesele with Sildenafil 90
Sep 20, 2016: Innovus Pharma Announces the U.S. Launch of Sensum+, a Clinically Proven Product to Increase Penile Sensitivity, on its Beyond Human Sales and Marketing Platform 91
Sep 19, 2017: Innovus Pharma Announces the Launch of Zestra in France, Belgium and Monaco by Its Partner, Densmore 92
Aug 30, 2016: Innovus Pharma Announces the Launch of RecalMax A Clinically Proven Product for Brain Health in the U.S. 93
Jun 13, 2016: Innovus Pharmaceuticals Announces Successful Top Line Results From RecalMax in Memory, Processing Speed and Thought MaintenanceC 94
Jun 01, 2017: Innovus Pharma Announces Positive Pre-Clinical Synergistic Effects of Vesele in Combination with Sildenafil on Nitric Oxide Production 95
May 24, 2017: Innovus Pharma Launches AllerVarx, a Clinically Proven Supplement for the Relief of Allergy Symptoms, in the United States 96
May 01, 2017: Innovus Pharma Launches ProstaGorx Product for Prostate Health Through its Beyond Human Sales and Marketing Platform in the United States 97
Other Significant Developments 98
Aug 09, 2017: Innovus Pharma Orders its First Commercial Batch of 220,000 Units of FlutiCare 98
Apr 05, 2017: Innovus Pharma Announces Receipt of Notification to Commercialize Zestra Glide in the European Union 99
Mar 02, 2017: Innovus Pharma Announces Receipt of Notification to Commercialize Zestra in the European Union 100
Aug 04, 2016: Innovus Pharma Resumes Commercial Sale of Zestra With the Appointment of PT Laras Bumi Resources as Its Distributor for Select Asian Countries Including Japan, Korea, Indonesia and China 101
Appendix 102
Methodology 102
About GlobalData 102
Contact Us 102
Disclaimer 102
Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 8
Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 9
Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 10
Innovus Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 11
Innovus Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 12
Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13
Innovus Pharma Acquires Assets of Beyond Human for USD0.6 Million 17
Innovus Pharma Acquires Vesele from Trophikos 18
Innovus Pharma Amends Acquisition of Rights to Circumserum from Centric Research for up to USD7.5 Million 19
Innovus Pharma To Acquire Prescription Product Portfolio From Prospector Capital Partners II 20
Innovus Pharma Raises US$0.33 Million In Venture Financing 22
Innovus Pharma To Raise US$1.1 Million In Venture Financing 23
Innovus Pharma Enters into Agreement with ACON Laboratories 24
Innovus Pharma Enters into Distribution Agreement with Laboratorios Q Pharma 25
Innovus Pharma Enters into Co-Marketing Agreement with DanaLife for Zestra 26
Innovus Pharma Enters Into Co-Promotion Agreement With Consortia Health For EjectDelay 27
Innovus Pharma Plans to Enter into Licensing Agreement with University of Iowa Research Foundation 28
Luminarie Enters into Licensing Agreement with Innovus Pharma 29
Innovus Pharma Expands Licensing Agreement with Densmore for Zestra 30
Innovus Pharma Enters into Licensing Agreement with NTC 31
Innovus Pharma Enters into Licensing Agreement with J&H Co. for Zestra 32
Elis Pharma Enters into Licensing Agreement with Innovus Pharma for Zestra 33
Innovus Pharma Enters into Licensing Agreement with BroadMed for EjectDelay 34
Innovus Pharma Enters into Licensing Agreement with Seipel 35
Bio Task Enters into Licensing Agreement with Innovus Pharma 36
Khandelwal Labs Enters into Licensing Agreement with Innovus Pharma 37
Elis Pharma Enters into Licensing Agreement with Innovus Pharma 38
BroadMed Enters into Licensing Agreement with Innovus Pharma for Sensum+ 39
Innovus Pharma Entes into Licensing Agreement with Tabuk Pharma 40
Innovus Pharma Enters into Licensing Agreement with Sothema Labs 41
Orimed Pharma Expands Licensing Agreement with Innovus Pharma 42
Innovus Pharma Enters into Licensing Agreement with Tramorgan for Sensum+ 43
Innovus Pharma Enters Into Licensing Agreement With Ovation Pharma For EjectDelay 44
Innovus Pharma Enters Into License And Distribution Agreement With Ovation Pharma For Circumserum 45
Innovus Pharma Raises Funds through Private Placement 46
Innovus Pharma Prices Public Offering of Shares for USD3.9 Million 47
Innovus Pharma Files Registration Statement for Public Offering of Shares and Warrants for up to USD5 Million 48
Innovus Pharma to Raise Funds in Public Offering of Shares 49
Innovus Pharma to Raise USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 50
Innovus Pharma Completes Private Placement Of Shares For US$0.13 Million 51
Innovus Pharma Completes Private Placement Of Shares For US$0.45 Million 52
Innovus Pharma Completes Private Placement Of Shares For US$4.5 Million 53
Innovus Pharma Raises USD0.8 Million in Third and Final Tranche of Private Placement of 10% Notes Due 2017 54
Innovus Pharma Raises Additional USD0.75 Million in Private Placement of 10% Note Due 2017 55
Innovus Pharma Raises USD1.5 Million in Private Placement of 10% Note Due 2017 56
Innovus Pharma Raises USD0.5 Million in Private Placement of 5% Notes Due 2016 57
Innovus Pharma to Raise USD0.3 Million Private Placement of 5% Notes Due 2016 58
Innovus Pharma to Raise USD0.3 Million Private Placement of 5% Notes Due 2016 59
Innovus Pharma Raises USD0.1 Million in Private Placement of Notes 60
Innovus Pharma Raises USD0.1 Million in Private Placement of 8% Debentures 61
Innovus Pharma Amends Private Placement of 8% Debenture Due 2016 62
Innovus Pharma Raises USD0.3 Million in Private Placement of 10% Debentures due 2015 63
Innovus Pharma Raises USD0.4 Million in Private Placement of 8% Debentures due 2014 64
Innovus Pharma Raises USD0.1 Million in Private Pacement of Convertible Debt 65
Innovus Pharma Raises USD0.2 Million in Private Placement of 8% Debentures 66
Apricus Biosciences Acquires Remaining 50% Stake Of Rights To PrevOnco From Innovus Pharma 67
Innovus Pharma Acquires Novalere 68
Innovus Pharma Acquires Semprae Labs 69
Innovus Pharmaceuticals Inc, Key Competitors 70
Innovus Pharmaceuticals Inc, Key Employees 71
Innovus Pharmaceuticals Inc, Subsidiaries 72